Tessera Defense & Homeland Security Inc.
Close on Oct 19, 2026
- Market cap
- $2.30M
- P/E (TTM)
- 0.0
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | Before market open | – | $-0.29 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | Before market open | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | Before market open | – | $0.33 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 25, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 14, 2024 | Before market open | – | $-0.31 | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 3, 2024 | Before market open | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 14, 2023 | Before market open | – | $-0.13 | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 9, 2023 | Before market open | – | – | – |
| Q1 FY2023 Ended Mar 31, 2023 | May 15, 2023 | Before market open | – | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 29, 2023 | Before market open | – | – | – |
| Q3 FY2022 Ended Sep 30, 2022 | Nov 9, 2022 | Before market open | – | – | – |
| Q1 FY2022 Ended Mar 31, 2022 | May 11, 2022 | Before market open | – | – | – |
Press releases
Announcements Tessera Defense & Homeland Security filed with the SEC
PRESS RELEASE DATED OCTOBER 7, 2026
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED SEPTEMBER 29, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE OF TESSERA DEFENSE AND HOMELAND SECURITY INC. DATED SEPTEMBER 15, 2026, INCLUDING LETTER TO STOCKHOLDERS
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
CORPORATE PRESENTATION DATED SEPTEMBER 2026
Charter or bylaw amendment · Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE OF BIOMX INC., DATED SEPTEMBER 1, 2026
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF BIOMX INC., DATED JUNE 18, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESENTATION OF BIOMX INC., DATED JUNE 2026
Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE OF BIOMX INC., DATED JUNE 12, 2026
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED APRIL 16, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED ON APRIL 13, 2026
Material agreement · Acquisition or disposition completed · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED APRIL 10, 2026
Material agreement · Acquisition or disposition completed · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 27, 2026
Listing notice · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 19, 2026
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 12, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 13, 2025
Results of operations · EX-99.1 to Form 8-K
CORPORATE PRESENTATION DECK DATED JULY 8, 2025
Regulation FD disclosure · EX-99.2 to Form 8-K
INVESTOR PRESENTATION DATED JUNE 9, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED MAY 15, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 31, 2025, TITLED "BIOMX ANNOUNCES POSITIVE RESULTS FROM PHASE 2 TRIAL EVALUATING BX211 FOR THE TREATMENT OF DIABETIC FOOT OSTEOMYELITIS (DFO)"
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DECK DATED FEBRUARY 26, 2025
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED MARCH 25, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED FEBRUARY 26, 2025
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DECK DATED FEBRUARY 26, 2025
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED NOVEMBER 14, 2024
Results of operations · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED SEPTEMBER 26, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED APRIL 3, 2024
Results of operations · EX-99.1 to Form 8-K
FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
The undersigned signatory of this lock-up agreement
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.2 to Form 8-K
INVESTOR PRESENTATION, DATED MARCH 6, 2024
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.3 to Form 8-K
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED NOVEMBER 29, 2023
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 14, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 9, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MAY 15, 2023
Results of operations · Executive or director change · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 29, 2023
Results of operations · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED FEBRUARY 22, 2023
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED JANUARY 26, 2023
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 9, 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED NOVEMBER 9, 2022
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K